Composition
- Active ingredients
- REGORAFENIB 40MG
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA209728.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Regorafenib
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Actavis Labs FL
- Status
- Discontinued
- FDA approval
- 13 Jan 2025
- Application
- ANDA209728-001